Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
770 participants
INTERVENTIONAL
2022-06-24
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Helping In-patients to Quit Smoking by Understanding Their Risk Perception, Behavior, and Attitudes Related to Smoking
NCT02866760
Smoking Cessation Among People Attending A&E
NCT02660957
Mobile Phone-Based Smoking-Cessation Intervention for Chronic Patients
NCT06187142
Personalized Support Using Instant Messaging Applications to Increase Smoking Cessation
NCT03800719
Deliver an Evidence-based Smoking Cessation Intervention for Smokers Attending A&E Departments in Hong Kong
NCT03818360
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Mobile phones are increasingly used for monitoring and delivering personalised health treatments (mHealth). Regular text messaging was found to increased 6-months validated abstinence in general smokers, although the study was limited to pre-defined messages and interactions. A previous study reported an automated interactive voice response to be favored by patients and to increase abstinence. A text-based programme was tested in a Chinese population, and previous study found the delivery of interactive chat-based SC support via IM apps to be effective in increasing quitting. Chat-based SC interventions can provide real-time, personalised behavioral support and referrals to SC services. Mobile health is also part of the World Health Organization's strategies to combat smoking.
Leveraging the success of previous trials in inpatients and a chat-based trial using IM to deliver behavioral support to community smokers, This study proposes to refine the 5As cessation model by incorporating a mobile phone-based intervention for patients recently discharged from hospitals. Recent trials showed a mobile phone-delivered cessation intervention combined with SC medication service increased abstinence. Recent trials showed a mobile phone-delivered cessation intervention combined with SC medication service increased abstinence. Active referral of community smokers to smoking cessation services increases service use and quitting but smoking patients were not referred for sustained cessation service in hospitals in Hong Kong. The effect of mobile phone-based intervention with active referral to link discharged patients for standard smoking cessation service remains unclear. Therefore, This study proposes to enhance the general 5As brief advice model with interactive mobile phone-based intervention and active referral to community smoking cessation services for smoking patients discharged from hospitals in Hong Kong.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
5As brief advice + Self-help ebooklet + Nurse-led mHealth intervention
5As brief advice
Participants will receive brief face-to-face advice following a 5As model at baseline:
1. Ask: Smoking patients will be asked about their smoking status.
2. Advise: Smoking patients will be advised to quit in a clear and personalised manner, with a focus on smoking-related diseases.
3. Assess: Smoking patients will be assessed for their readiness to quit by assessing their self-efficacy and perceived importance.
4. Assist: Those who are ready to quit will be assisted in setting a quit plan.
5. Arrange: Refer to smoking cessation services.
Self-help e-booklet
A 12-page generic self-help smoking cessation e-booklet via IM apps, including:
1. Highlights of the absolute risk of death due to smoking;
2. Smoking and diseases management;
3. Ten horrible pictorial warnings of health consequences of smoking and second-hand smoking;
4. Benefits of quitting;
5. Methods to quit and handle. withdrawal symptoms.
Nurse-led mHealth intervention
Participants will receive real-time mHealth behaviour and psychosocial support for 12 weeks after baseline through IM apps. mHealth intervention consists of two main parts: regular instant messaging on smoking cessation and personalized real-time mHealth chatting on smoking and disease (including active referral to smoking cessation service)
Control group
5As brief advice + Self-help ebooklet + Text messaging
5As brief advice
Participants will receive brief face-to-face advice following a 5As model at baseline:
1. Ask: Smoking patients will be asked about their smoking status.
2. Advise: Smoking patients will be advised to quit in a clear and personalised manner, with a focus on smoking-related diseases.
3. Assess: Smoking patients will be assessed for their readiness to quit by assessing their self-efficacy and perceived importance.
4. Assist: Those who are ready to quit will be assisted in setting a quit plan.
5. Arrange: Refer to smoking cessation services.
Self-help e-booklet
A 12-page generic self-help smoking cessation e-booklet via IM apps, including:
1. Highlights of the absolute risk of death due to smoking;
2. Smoking and diseases management;
3. Ten horrible pictorial warnings of health consequences of smoking and second-hand smoking;
4. Benefits of quitting;
5. Methods to quit and handle. withdrawal symptoms.
Regular intervention
Participants will receive text messages using IM app with content on general health and reminding the importance of participating in the follow-up surveys and biochemical validation for quitting.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
5As brief advice
Participants will receive brief face-to-face advice following a 5As model at baseline:
1. Ask: Smoking patients will be asked about their smoking status.
2. Advise: Smoking patients will be advised to quit in a clear and personalised manner, with a focus on smoking-related diseases.
3. Assess: Smoking patients will be assessed for their readiness to quit by assessing their self-efficacy and perceived importance.
4. Assist: Those who are ready to quit will be assisted in setting a quit plan.
5. Arrange: Refer to smoking cessation services.
Self-help e-booklet
A 12-page generic self-help smoking cessation e-booklet via IM apps, including:
1. Highlights of the absolute risk of death due to smoking;
2. Smoking and diseases management;
3. Ten horrible pictorial warnings of health consequences of smoking and second-hand smoking;
4. Benefits of quitting;
5. Methods to quit and handle. withdrawal symptoms.
Nurse-led mHealth intervention
Participants will receive real-time mHealth behaviour and psychosocial support for 12 weeks after baseline through IM apps. mHealth intervention consists of two main parts: regular instant messaging on smoking cessation and personalized real-time mHealth chatting on smoking and disease (including active referral to smoking cessation service)
Regular intervention
Participants will receive text messages using IM app with content on general health and reminding the importance of participating in the follow-up surveys and biochemical validation for quitting.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Smoke cigarettes or alternative tobacco products (e.g. electronic cigarettes or heated tobacco products) daily at 1 month prior to hospitalisation
3. Have a smartphone with an IM app (WhatsApp or WeChat) and experience in using the app
4. Hong Kong adult residents (18+) able to communicate in Chinese (Cantonese or Mandarin)
Exclusion Criteria
2. Smokers currently using SC medication or other SC services
3. Smokers hospitalised for more than 1 month
4. Perceived difficulty to use IM after discharge
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Queen Mary Hospital, Hong Kong
OTHER
Princess Margaret Hospital, Hong Kong
OTHER_GOV
Queen Elizabeth Hospital, Hong Kong
OTHER
Kwong Wah Hospital
OTHER
The University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Wang Man-Ping
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Man Ping Wang, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Nursing, The University of Hong Kong
Hong Kong, Hong Kong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HKU Clinical Trials Registry
Identifier Type: REGISTRY
Identifier Source: secondary_id
SC discharge
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.